Biocon Biologics, Viatris receive EC approval for biosimilar insulin aspart Kixelle

Biocon Biologics, Viatris receive EC approval for biosimilar insulin aspart Kixelle This follows the positive recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency, a Biocon statement said on Friday.

No comments:

Post a Comment